Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases, focusing on respiratory fungal infections
Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases, focusing on respiratory fungal infections. Their lead product, opelconazole, is an investigational inhaled antifungal therapy designed to treat invasive pulmonary aspergillosis.